The global cell-based assays market is projected to reach US$ 40.4 billion by 2034, driven by increasing demand for drug development and biomedical research. Cell-based assays provide several advantages over traditional methods, offering a more accurate and physiologically relevant approach to analyzing drug properties. The market is segmented by product type, application, end user, and region, with North America leading the market due to significant drug discovery research and rising prevalence of chronic illnesses.